Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin
NCT04109404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2019-10-11
Summary
Investigators observe an increase risk of meningioma in patient treated by CYPROTERONE ACETATE or other form of progestin. Investigatorsdiscribe caractéristics of meningioma and treatement of the patients follow up in CHRU of Brest
Conditions
- Meningioma
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Principal Investigators
-
Véronique KERLAN, PH · Service d'Endocrinologie-Diabétologie - CHRU de Brest
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-25
- Primary Completion
- 2019-06-01
- Completion
- 2019-06-01
Countries
- France
Study Locations
More Related Trials
-
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
NCT00372697 ·Status: COMPLETED ·Phase: PHASE3
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
Acute Application of Pegvisomant and Octreotide in Acromegaly
NCT00595140 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Study of Hormonal Regulation of Infantile Hemangioma
NCT00004436 ·Status: COMPLETED ·Phase: NA
-
Clomiphene Citrate for Treatment of Acromegaly
NCT02274311 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
NCT01397500 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury
NCT00555009 ·Status: TERMINATED ·Phase: PHASE4
-
Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet
NCT02049671 ·Status: UNKNOWN
-
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
NCT04867317 ·Status: RECRUITING ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome)
NCT02297048 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Brain-gut Interaction in Irradiated Patients With Acromegaly
NCT02005978 ·Status: UNKNOWN
-
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
NCT00376064 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients
NCT00210457 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Patterns and Treatment Outcomes for Acromegaly
NCT03043586 ·Status: COMPLETED
-
Somatuline Predictive Factors in Acromegaly and NET
NCT01840449 ·Status: COMPLETED
-
Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity
NCT01028742 ·Status: COMPLETED
-
Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents
NCT00140842 ·Status: COMPLETED
-
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
NCT00422201 ·Status: TERMINATED ·Phase: PHASE2
-
Acromegaly Treatment Quality of Life Study
NCT01732406 ·Status: COMPLETED
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Preoperative Octreotide Treatment of Acromegaly
NCT00521300 ·Status: COMPLETED ·Phase: PHASE4
-
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
NCT01568359 ·Status: COMPLETED